SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (1014)6/16/2006 11:54:48 AM
From: Mike McFarlandRead Replies (1) of 1336
 
You know, I didn't give you a coherent answer
at all. Sorry about that.

If I had to sell GLGC stock, I could spin a
pretty good genomics "personalized medicine"
and "drug repositioning" story--and it would
sound okay to the man on the street. Especially
alongside valuation, trading under book value
and all that. But it would be a little fluffy.

I think I would have to redirect anybody to recent
conference calls and such--which I have not been
listening in on.

The stock is cheap for sure. But I would say that
there might be a lot of shares in weak hands,
and before I traded back in, maybe it would be
good to see some sort of capitulation from the
daytrader yahooligan types.

I am extraordinarily bad at reading the tea leaves.
It does look like it has bottomed--but maybe the
volume is too light to really have bottomed?
I guess the best thing to do is buy over a longer
period of time, buy a third of a positon etc etc.
(Like I ever do that, ha!)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News